Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Starts PTC Therapeutics (PTCT) at Overweight
-
Cantor Fitzgerald Starts Gilead Sciences (GILD) at Overweight
-
Cantor Fitzgerald Transfers Coverage on Biogen (BIIB), Upgrades to Overweight
-
Cantor Fitzgerald Starts Tesaro (TSRO) at Overweight
-
Cantor Fitzgerald Starts Sarepta Therapeutics (SRPT) at Overweight
-
Opiant Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Opiant Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Apellis Pharmaceuticals to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Apellis Pharmaceuticals to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Abeona Announces Participation at Upcoming Conferences
-
Abeona Announces Participation at Upcoming Conferences
-
Agenus to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference in New York, NY
-
TG Therapeutics, Inc. to Present at Upcoming Investor Conferences
-
UPDATE: Opiant Pharma (OPNT) PT Raised to $42 at Cantor Fitzgerald
-
Teladoc (TDOC) PT Raised to $83 at Cantor Fitzgerald Following Investor Day
-
Aldeyra Therapeutics (ALDX) Prices 5.25M Share Common Offering at $13.75/Sh
-
Aldeyra Therapeutics, Inc. Announces Public Offering of Common Stock
-
Veru to Present at Upcoming Healthcare Investor Conferences in New York
-
XOMA to Present at the Cantor Fitzgerald Healthcare Conference 2018 and the 2018 BIO Investor Forum
-
Cantor Fitzgerald Downgrades MedEquities Realty Trust (MRT) to Neutral
-
Cantor Fitzgerald Upgrades HCP (HCP) to Overweight
-
Veracyte to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Verastem Oncology to Present at Upcoming Investor Conferences
-
Regulus to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Merus to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Merus to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Ra Medical Systems (RMED) IPO Opens 26% Higher
-
GW Pharma (GWPH) Last Box Checked Off With Best Possible DEA Rescheduling - Cantor
-
Novavax (NVAX) Phase 2 Failure Represents Significant Lost Opportunity - Cantor Fitzgerald
-
Veru, Inc. (VERU) Prices 7.14M Common Stock Offering at $1.40/Share
-
Veru Announces Pricing of Public Offering of Common Stock
-
WellCare Health Plans (WCG) Acquiring Aetna Part D Is A Positive - Cantor Fitzgerald
-
ANI Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Heron Therapeutics (HRTX) Defended at Cantor
-
Hamilton Zanze and Cantor Fitzgerald Acquire The Quarters at Towson Town Center Apartment Community Through Second Joint Venture
-
Endocyte to Present at Two Investor Conferences on October 2nd
-
Endocyte to Present at Two Investor Conferences on October 2nd
-
SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on October 2, 2018
-
Cantor Offers Thoughts On Teva Pharma (TEVA) Weakness
-
X4 Pharmaceuticals Appoints Adam Mostafa as Chief Financial Officer
-
Ra Medical Systems, Inc. (RMED) Prices 3.9M Share IPO at $17/Sh
-
Ra Medical Systems Announces Pricing of Initial Public Offering
-
MacroGenics Announces Participation in Two Upcoming Investor Conferences
-
Vanda Pharmaceuticals Announces Participation at Oppenheimer and Cantor Fitzgerald Fall 2018 Investor Conferences
-
MacroGenics Announces Participation in Two Upcoming Investor Conferences
-
Dova Pharmaceuticals to Present at Upcoming Investor Conferences
-
Dova Pharmaceuticals to Present at Upcoming Investor Conferences
-
Cantor Fitzgerald Starts CIGNA (CI) at Overweight
-
Curis to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Veru, Inc. (VERU) Announces Proposed Common Share Offering


